• <em>Lobelia chinensis</em> Extract and Its Active Compound, Diosmetin, Improve Atopic Dermatitis by Reinforcing Skin Barrier Function through SPINK5/LEKTI Regulation
• <em>Staphylococcus aureus</em> proteases trigger eosinophil-mediated skin inflammation
• <em>Staphylococcus aureus</em> Proteases: Orchestrators of Skin Inflammation
• A case of neonatal Netherton syndrome
• A Netherton syndrome case report: Response to dupilumab treatment
• A Netherton syndrome infant complicated with infective endocarditis
• A novel mutation in <em>SPINK5</em> gene underlies a case of atypical Netherton syndrome
• A novel mutation in SPINK5 gene underlies a case of atypical Netherton syndrome
• A novel pathogenic variant in the corneodesmosin gene causing generalized inflammatory peeling skin syndrome with marked eosinophilia and trichorrhexis invaginata
• A Novel SPINK5 Gene Mutation Associated with Netherton Syndrome in an Omani Patient
• Analysis of the structure and function of the epidermal barrier in patients with ichthyoses-clinical and electron microscopical investigations
• Atopic Dermatitis-like Genodermatosis: Disease Diagnosis and Management
• Biological treatments for pediatric Netherton syndrome
• Biologics for inherited disorders of keratinisation: A systematic review
• Case report: Interleukin-17 targeted biological therapy in netherton syndrome
• Chemogenetic control of GABAergic activity within the interpeduncular nucleus reveals dissociable behavioral components of the nicotine withdrawal phenotype
• Classic and Simultaneous Clinical Findings of an Exuberant Case of Netherton Syndrome: A Clinical Report
• Clinical and genetic characterization of Netherton syndrome due to SPINK5 founder variant in Latvian population
• Clinical and molecular characteristics of autosomal recessive congenital ichthyosis in Thailand
• Cocktails of KLK5 Protease Inhibitors and Anti-TNFalpha Therapeutics: an Effective Treatment for Netherton Syndrome
• Cocktails of KLK5 Protease Inhibitors and Anti-TNFα Therapeutics: an Effective Treatment for Netherton Syndrome
• Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways
• Dermoscopic and reflectance confocal microscopy features of Netherton syndrome
• Development of a back-titration assay to quantitate functional lympho-epithelial Kazal-type inhibitors (LEKTI) in skin samples
• Distinct skin microbiome community structures in congenital ichthyosis
• Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis
• Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation
• Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study
• Dupilumab in Inflammatory Skin Diseases: A Systematic Review
• Dupilumab in paediatric Netherton syndrome: Can we do better?
• Dupilumab in the treatment of genodermatosis: A systematic review
• Dupilumab zur Behandlung von Genodermatosen: Eine systematische Übersicht
• Editorial: Time, genetics, and complex disease
• Effective treatment of Netherton syndrome in children with dupilumab: a case report and review of the literature
• Effective treatment of topical corticosteroid-resistant dermatitis with delgocitinib in a pediatric patient with Netherton syndrome
• Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases
• Erythroderma in a neonate
• Erythrokeratodermia Variabilis-like Phenotype in Patients Carrying <em>ABCA12</em> Mutations
• Establishment of a mouse model of Netherton syndrome based on CRISPR/Cas9 technology
• Giant condyloma of Buschke-Lowenstein in a Netherton syndrome patient, successfully treated with cryotherapy and intravenous immunoglobulin
• Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases
• IgE Sensitization Profile in Patients with Netherton Syndrome
• Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
• Interprofessional Collaboration: Differentiating Netherton Syndrome and Atopic Dermatitis in an African American Infant
• Intravenous immunoglobulin for the management of Netherton syndrome
• Journal club Update on systemic therapies in paediatric dermatology
• Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature
• Measurement of clinical outcomes of Netherton syndrome following treatment with upadacitinib
• Mini-PBPK-Based Population Model and Covariate Analysis to Assess the Complex Pharmacokinetics and Pharmacodynamics of RO7449135, an Anti-KLK5/KLK7 Bispecific Antibody in Cynomolgus Monkeys
• Multidimensional response of Dupilumab in a child affected by Netherton syndrome: Improvement of trichorrhexis invaginata
• Multiplex Proteomic Evaluation in Inborn Errors with Deregulated IgE Response
• Multiscale modelling of desquamation in the interfollicular epidermis
• Netherton Syndrome
• Netherton syndrome and papillomatous lesions-Should we perform human papilloma virus vaccination?
• Netherton Syndrome Caused by Heterozygous Frameshift Mutation Combined with Homozygous c.1258A&gt;G Polymorphism in <em>SPINK5</em> Gene
• Netherton Syndrome Caused by Heterozygous Frameshift Mutation Combined with Homozygous c.1258A>G Polymorphism in SPINK5 Gene
• Netherton syndrome in a Bulgarian patient : Presentation of a case and an update of therapeutic options
• Netherton Syndrome in a Mother and Her Two Children
• Netherton Syndrome in Thai Children: A Report of Two Cases With a Literature Review
• Netherton Syndrome with a Novel Likely Pathogenic Variant c.420del (p.Ser141ProfsTer5) in SPINK5 Gene: A Case Report
• Netherton syndrome with chromosome 16p11.2 microduplication in a Chinese infant
• Netherton syndrome-A therapeutic challenge in childhood
• New developments in the molecular treatment of ichthyosis: review of the literature
• Novel splice site mutation at the C-terminal of SPINK5 cause a unique Netherton syndrome phenotype mimicking pustular psoriasis
• Oral Tofacitinib Therapy for the Effective Management of Netherton Syndrome
• Outcomes of Systemic Treatment in Children and Adults With Netherton Syndrome: A Systematic Review
• Persistent methicillin-resistant Staphylococcus aureus bacteremia in an adult patient with Netherton's syndrome: A case report
• Personal, financial and time burden in inherited ichthyoses: A survey of 144 patients in a university-based setting
• Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their <em>In Vivo</em> Delivery to the Skin
• Prevalence of and risk factors for nutritional deficiency and food allergy in a cohort of 21 patients with Netherton syndrome
• Proposal for a 6-step approach for differential diagnosis of neonatal erythroderma
• Psychological Adjustment in Apert Syndrome: Parent and Young Person Perspectives
• Pulsed dye laser for facial erythema in Netherton syndrome
• Recombinant scFv-Fc Anti-kallikrein 7 Antibody-Loaded Thermosensitive Hydrogels Against Skin Desquamation Disorders
• Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature
• Secukinumab for Netherton syndrome: a Malaysian experience
• Secukinumab responses vary across the spectrum of congenital ichthyosis in adults
• Secukinumab use in the treatment of Netherton's syndrome
• Secukinumab: A life-changing treatment for Netherton syndrome?
• Severe Hypernatremia as Presentation of Netherton Syndrome
• Significant response to Pembrolizumab for metastatic cutaneous squamous cell carcinoma in patient with Netherton syndrome
• Skin Microbiota and Clinical Associations in Netherton Syndrome
• SPINK5 mutation and FLG gene deletion in an infant with Netherton syndrome
• Successful infliximab treatment in siblings with Netherton syndrome: Unveiling a novel SPINK5 gene variant and literature review
• Successful treatment of dupilumab-resistant scaly erythroderma in Netherton syndrome with baricitinib: A case report
• The potential role for phage therapy for genetic modification of cutaneous diseases
• The realistic positioning of UVA1 phototherapy after 25 years of clinical experience and the availability of new biologics and small molecules: a retrospective clinical study
• The role of interleukin-36 in health and disease states
• Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier Signatures
• Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series
• Treatment of Netherton Syndrome in Pediatrics with Upadacitinib
• Treatment of Netherton Syndrome With Abrocitinib
• Treatment of Netherton syndrome with dupilumab
• Treatment of Netherton syndrome with spesolimab
• Treatment of Netherton syndrome with upadacitinib
• Two Incidental Sibling Diagnoses of Netherton Syndrome in Separate Visits: A Case Report
• Understanding immune profiles in ichthyosis may lead to novel therapeutic targets
• Unique Usages of Dehydrated Human Amnion Chorion Membrane Allografts in Dermatology
• Ustekinumab therapy for Netherton syndrome
• Vulvovaginal involvement in Netherton syndrome: A case report